Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alena Shantsila

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
JACC. Asia|May 6, 2026
Right Bundle Branch Block: A Novel Marker of Systemic Endothelial DysfunctionAlena Shantsila
JACC. Asia|January 31, 2025
Childhood Blood Pressure Control in Relation to Arterial Stiffness in AdulthoodLily Jones, Alena Shantsila
Seminars in Thrombosis and Hemostasis|September 10, 2009
Microparticles and arterial diseaseAndrew Blann, Eduard Shantsila, Alena Shantsila
Evidence-Based Medicine|October 2, 2009
Review: combining 2 classes of blood pressure-lowering drugs has an approximately additive effect on systolic blood pressureAlena Shantsila, Gregory Y H Lip
Annals of Internal Medicine|April 19, 2017
Guideline: ACP and AAFP recommend systolic BP targets based on history and risk level in adults ≥ 60 years of ageAlena Shantsila, Gregory Y H Lip
American Journal of Hypertension|February 16, 2017
Malignant Hypertension Revisited-Does This Still Exist?Alena Shantsila, Gregory Y H Lip
Annals of Internal Medicine|April 21, 2020
In patients with SBP ≥ 130 mm Hg and CV risk, intensive vs standard BP control did not increase fear of fallingAlena Shantsila, Gregory Y H Lip
Annals of Internal Medicine|August 4, 2025
In uncontrolled hypertension, adding lorundrostat to a standardized AHT regimen reduced SBP at 12 wkAlena Shantsila, Gregory Y H Lip,
Journal of Hypertension|January 15, 2019
Malignant hypertension: not quite an obsolete diagnosis yetAlena Shantsila, Gregory Y H Lip
Annals of Internal Medicine|August 19, 2009
ACP Journal Club. Review: Combining 2 classes of blood pressure-lowering drugs has an approximately additive effect on systolic blood pressureAlena Shantsila, Gregory Y H Lip
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
JACC. Asia|May 6, 2026
Right Bundle Branch Block: A Novel Marker of Systemic Endothelial DysfunctionAlena Shantsila
JACC. Asia|January 31, 2025
Childhood Blood Pressure Control in Relation to Arterial Stiffness in AdulthoodLily Jones, Alena Shantsila
Seminars in Thrombosis and Hemostasis|September 10, 2009
Microparticles and arterial diseaseAndrew Blann, Eduard Shantsila, Alena Shantsila
Evidence-Based Medicine|October 2, 2009
Review: combining 2 classes of blood pressure-lowering drugs has an approximately additive effect on systolic blood pressureAlena Shantsila, Gregory Y H Lip
Annals of Internal Medicine|April 19, 2017
Guideline: ACP and AAFP recommend systolic BP targets based on history and risk level in adults ≥ 60 years of ageAlena Shantsila, Gregory Y H Lip
American Journal of Hypertension|February 16, 2017
Malignant Hypertension Revisited-Does This Still Exist?Alena Shantsila, Gregory Y H Lip
Annals of Internal Medicine|April 21, 2020
In patients with SBP ≥ 130 mm Hg and CV risk, intensive vs standard BP control did not increase fear of fallingAlena Shantsila, Gregory Y H Lip
Annals of Internal Medicine|August 4, 2025
In uncontrolled hypertension, adding lorundrostat to a standardized AHT regimen reduced SBP at 12 wkAlena Shantsila, Gregory Y H Lip,
Journal of Hypertension|January 15, 2019
Malignant hypertension: not quite an obsolete diagnosis yetAlena Shantsila, Gregory Y H Lip
Annals of Internal Medicine|August 19, 2009
ACP Journal Club. Review: Combining 2 classes of blood pressure-lowering drugs has an approximately additive effect on systolic blood pressureAlena Shantsila, Gregory Y H Lip
Pageof 13